Patents currently prevent a generic Sklice (ivermectin lotion) from being manufactured in the United States. The earliest predictable date that a generic version could become available is May 2018, when the first patent expires. However, lawsuits or other patents for new uses may delay the manufacturing of a generic version of the drug.
Can I Buy Generic Sklice?Sklice® (ivermectin lotion) is a prescription head lice medication. It can be used in children as young as six months of age. It comes as a lotion that is applied for 10 minutes for one treatment.
Sklice is manufactured by DPT Laboratories LTD for Sanofi Pasteur, Inc. In the United States, Sklice is protected by patents and is not available in generic form at this time.
When Will a Generic Version Be Available?The first patent for Sklice is set to expire in May 2018. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for new Sklice uses. Once the patent expires, there may be several companies that manufacture a generic Sklice drug.
Is Ivermectin a Generic Sklice?No -- ivermectin is the active ingredient in Sklice (as well as in one other human medication and several veterinary medications), but is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.